Charles Schwab’s Rapport Therapeutics RAPP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.06M	Buy	93,497 +2,529	+3%	+$28.8K	﹤0.01%	2879
2025 Q1	$912K	Buy	90,968 +17,459	+24%	+$175K	﹤0.01%	2874
2024 Q4	$1.3M	Buy	73,509 +363	+0.5%	+$6.44K	﹤0.01%	2817
2024 Q3	$1.5M	Buy	+73,146	New	+$1.5M	﹤0.01%	2791